Trial Profile

A clinical trial of Salinomycin in the patients with solid tumours

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 02 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Salinomycin (Primary)
Indications Solid tumours
Focus Adverse reactions

Most Recent Events

27 Apr 2023 According to Hillstream Biopharma media release, the company plans to initiate this study in the second half of 2023.
10 Apr 2023 According to Hillstream Biopharma media release, the company expect to submit IND in the second half of 2023 with HSB-1216.
17 Jan 2023 According to Hillstream Biopharma media release, the company intends to initate IND discussions with the FDA in first half of 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com